Aayurnil Med Agro Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.47 Cr
- Revenue Growth 11.38%
- Profit Growth 44.23%
- Ebitda 10.94%
- Net Worth 53.23%
- Total Assets -2.26%
About Aayurnil Med Agro
Aayurnil Med Agro Private Limited (AMAPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 March 2017 (Seven years and 11 months 15 days old ). Its registered office is in Sangli, Maharashtra, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹3.47 Cr.
Swati Shelke, Sachinkumar Shelke, Shivaji Shelake, and One other member serve as directors at the Company.
Company Details
- Location
Sangli, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U01110PN2017PTC169345
- Company No.
169345
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Mar 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Aayurnil Med Agro?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Swati Shelke  | Director | 10-Mar-2017 | Current |
| Sachinkumar Shelke | Director | 10-Mar-2017 | Current |
| Shivaji Shelake | Director | 10-Mar-2017 | Current |
| Kamal Shelake | Director | 10-Mar-2017 | Current |
Financial Performance of Aayurnil Med Agro.
Aayurnil Med Agro Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 11.38% increase. The company also saw a substantial improvement in profitability, with a 44.23% increase in profit. The company's net worth Soared by an impressive increase of 53.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aayurnil Med Agro?
In 2022, Aayurnil Med Agro had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aayurnil Medico LlpSwati Shelke and Sachinkumar Shelke are mutual person
Charges (Loans)
₹34.69 M
₹0
Charges Breakdown by Lending Institutions
- Others : 3.47 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Dec 2018 | Others | ₹4.59 M | Open |
| 30 Dec 2017 | Others | ₹3.01 Cr | Open |
How Many Employees Work at Aayurnil Med Agro?
Unlock and access historical data on people associated with Aayurnil Med Agro, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aayurnil Med Agro, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aayurnil Med Agro's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.